• World Cancer Day 2024

    EORTC on Closing the Cancer Care Gap – World Cancer Day 2024

  • The Horizon Europe Cancer Cluster

    The Horizon Europe Cancer Cluster

  • EORTC supports World Cancer Day 2023

    EORTC supports World Cancer Day 2023

  • “Clinical Trials: the patient in academic studies”

Press Releases

Latest Newsletters


Filter on topic
  • Rare-disease-day


    EORTC: Advancing research and treatment for rare cancers

  • 20-year-fellowship-report


    EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • News

    Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • EORTC EMA workshops


    Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • Ravina-Trial

    Head and Neck Cancer Group,News

    EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • IMMUcan abstracts at ESMO Immuno-Oncology 2023

    Breast Cancer Group,Imaging Group,Lung Cancer Group,News

    Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

    News,Quality of Life Group

    EORTC Quality of Life measures integrated in CDISC

  • ATOM study

    Melanoma Group,News

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • acute myeloid leukaemia publication

    Leukemia Group,News

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • ESMO 2023 Madrid

    Breast Cancer Group,Head and Neck Cancer Group,Lung Cancer Group,News

    New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023